🇺🇸 FDA
Patent

US 7888386

3-(phenoxyphenylmethyl)pyrrolidine compounds

granted A61KA61K31/40A61P

Quick answer

US patent 7888386 (3-(phenoxyphenylmethyl)pyrrolidine compounds) held by Theravance, Inc. expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
54
CPC classes
A61K, A61K31/40, A61P, A61P13/10, A61P15/12